Patent · US Active

Reagents for treatment of hepatitis B virus (HBV) infection and use thereof

US10898505B2 · kind B2 · utility

1Cited by

1References

20Claims

0Family size

Assignee

Benitec Biopharma Limited · AU

Inventors

Tin Mao · San Bruno, US
Shih-Chu Kao · Fawn Drive, AU
David Suhy · San Ramon, US
Michael Wayne Graham · Jindalee, AU

Key dates

Filing date	May 6, 2016
Grant date	Jan 26, 2021
Priority date	—
Expiry date	Aug 20, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/11
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure relates to RNA interference (RNAi) reagents for treatment of hepatitis B virus (HBV) infection, compositions comprising same, and use thereof to treat individuals infected with HBV.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.